• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Sartorius (XTRA:SRT3) Posted Stronger Earnings, Is It Still Below Fair Value?

    Simply Wall St·08/04/2026 19:37:34
    Listen to the news

    What Sartorius’ Latest Earnings Mean For Shareholders

    Sartorius (XTRA:SRT3) reported second quarter 2026 sales of €911.8 million and net income of €65.9 million, compared with €884.3 million and €32.5 million a year earlier. Investors now have fresh numbers to reassess the stock.

    See our latest analysis for Sartorius.

    The latest earnings news appears to be feeding into sentiment, with Sartorius’ share price up 1.9% over the last 90 days, even though the year-to-date share price return is down 8.2%, while the 1-year total shareholder return is 27.1% against much weaker 3- and 5-year total shareholder returns.

    If Sartorius’ earnings momentum has you reassessing the sector, this is a good moment to scan other healthcare focused AI opportunities using the 128 healthcare AI stocks

    With Sartorius trading at €227.60 and sitting at a 25% discount to one intrinsic value estimate, as well as a 17% discount to the average analyst target, the real question is where fair value actually lies for this recent rebound.

    Price-to-Earnings of 80.1x for Sartorius: Is It Justified?

    Sartorius closed at €227.60 while trading on a P/E of 80.1x, which screens as expensive next to both peers and fair value estimates that use earnings as a reference point.

    The P/E multiple compares the current share price to earnings per share and is often used for profitable healthcare and life sciences companies where earnings are a key focus for investors.

    For Sartorius, the current 80.1x P/E suggests the market is paying a high price for each euro of current earnings. That is well above the estimated fair P/E of 37.1x and indicates a level the market could move toward if expectations cool. It is also higher than the 40.1x peer average and the 37.6x Global Life Sciences industry average, which highlights how full the current P/E looks in this context.

    Explore the SWS fair ratio for Sartorius

    Result: Price-to-Earnings of 80.1x (OVERVALUED)

    However, Sartorius still faces risks if high expectations embedded in the 80.1x P/E ease, or if sector sentiment weakens after a strong 1-year total return.

    Find out about the key risks to this Sartorius narrative.

    Another View on Sartorius Using Cash Flows

    The high 80.1x P/E ratio paints Sartorius as expensive, yet the SWS DCF model points in a different direction. On that view, the stock at €227.60 trades about 25.5% below an estimated future cash flow value of €305.37. Which signal should carry more weight for you?

    Look into how the SWS DCF model arrives at its fair value.

    SRT3 Discounted Cash Flow as at Aug 2026
    SRT3 Discounted Cash Flow as at Aug 2026

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Sartorius for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 248 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

    Next Steps

    With such mixed signals around Sartorius, it makes sense to move quickly and weigh the trade off between risks and potential upside for yourself. You can start with the 3 key rewards and 1 important warning sign.

    Looking For More Investment Ideas Beyond Sartorius?

    Do not stop with Sartorius. Broaden your watchlist now with fresh stock ideas so you are not relying on a single story to shape your next move.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.